Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • HIV

    Tag: hiv

    You Searched For "HIV"
    NIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant women

    NIH-Funded Clinical Trial to test safety of dapivirine vaginal ring, PrEP in pregnant women

    Medical Dialogues Bureau14 Feb 2020 10:00 AM IST
    The dapivirine vaginal ring slowly releases the anti-HIV drug dapivirine in the vagina and is replaced once a month. Two large, Phase 3 clinical...
    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Farhat Nasim3 Feb 2020 1:41 PM IST
    New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 2:48 PM IST
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 11:23 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Medical Dialogues Bureau10 Nov 2019 9:00 AM IST
    New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 9:30 AM IST
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    Farhat Nasim18 July 2019 3:58 PM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Farhat Nasim28 May 2019 4:21 PM IST
    New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

    Meghna A Singhania18 May 2019 2:08 PM IST
    New Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has...
    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Garima16 May 2019 9:35 AM IST
    In separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Farhat Nasim14 May 2019 4:57 PM IST
    Mumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok